Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Deferred Tax Assets / Liabilities ₹-19 Cr₹12 Cr₹30 Cr₹41 Cr₹26 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of NATCO PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of NATCO PHARMA is ₹-19 Cr based on Mar2024 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2024₹-19 Cr
Mar2023₹12 Cr
Mar2022₹30 Cr
Mar2021₹41 Cr
Mar2020₹26 Cr

How is Deferred Tax Assets / Liabilities of NATCO PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2024 ₹-19 Cr
Negative
Mar2023 ₹12 Cr
-58.80
Mar2022 ₹30 Cr
-27.12
Mar2021 ₹41 Cr
59.46
Mar2020 ₹26 Cr -

Compare Deferred Tax Assets / Liabilities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹13,886.5 Cr -2.8% -4.5% -25.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,900.0 Cr -1.3% 4.7% 3.3% Stock Analytics
DIVIS LABORATORIES ₹148,474.0 Cr 1.9% 1.5% 41.9% Stock Analytics
CIPLA ₹118,166.0 Cr 3.4% 0.1% -3.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹105,849.0 Cr -4.8% 1.9% 20.3% Stock Analytics
DR REDDYS LABORATORIES ₹92,553.6 Cr -0.1% -1% -11.3% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-2.8%

-4.5%

-25.2%

SENSEX

-1.5%

1.1%

1.2%


You may also like the below Video Courses